ResMed | RMD - Pre Tax Profit

Stock Price
207.92
Daily Change
3.77 1.85%
Monthly
-8.06%
Yearly
-16.21%
Q2 Forecast
197.82

ResMed reported $496.15M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Ansell USD 33.35M 74.15M Jun/2025
Artivion USD 11.4M 7.84M Dec/2025
AtriCure USD 394K 1.97M Mar/2026
Baxter International USD -756M 877M Dec/2025
Cochlear AUD 121.1M 155.6M Jun/2025
Cooper Companies USD 116.8M 137.4M Sep/2025
CSL USD 2.61B 1.21B Dec/2025
Dexcom USD 340.7M 40.7M Dec/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Fisher Paykel Healthcare NZD 296.9M 90.5M Jun/2025
Globus Medical USD 169.23M 25.24M Dec/2025
Haemonetics USD 59.97M 8.69M Dec/2025
Idexx Laboratories USD 355.44M 48.46M Mar/2026
Inogen USD -6.06M 467K Sep/2024
Insulet USD 113M 27.2M Mar/2026
Integra LifeSciences USD -2.41M 6.72M Mar/2026
Intuitive Surgical USD 955.6M 100.4M Dec/2025
Masimo USD 71.3M 3.6M Mar/2026
Medtronic USD 2.1B 224M Sep/2025
Philips EUR 466M 191M Dec/2025
Ramsay Health Care AUD 103.75M 54.35M Jun/2025
ResMed USD 496.15M 13.77M Dec/2025
Sigma Healthcare AUD 8.15M 7.4M Jul/2024
Sonic Healthcare AUD 402.01M 53.16M Jun/2025
Steris USD 257.8M 66.6M Dec/2025
Teleflex USD 218.94M 657.52M Dec/2025
Thermo Fisher Scientific USD 2.12B 295M Dec/2025